🔥Telegram İfşa

He's known as the #kissingbug doctor. Less than 2 weeks to go until the launch of our new film on #WorldChagasDay, made with Norman Beatty and Emerging Pathogens Institute about vital efforts to beat the rise of #Chagas in Florida. Watch the trailer now!

Growing concern around #H5N1 and the spread of #dengue emphasises the urgent need for therapeutics development. We support the International Pandemic Preparedness Secretariat #100DaysMission recommendation of a Therapeutics Roadmap for greater funding, leadership, structure and coordination. 👇

As #PrideMonth 🏳️‍🌈 comes to an end, we're reflecting on what it means to make the best science truly available to EVERYONE. We commit to continue working with communities to address the specific needs of diverse populations. #PRIDE 🌈

DNDi is proud to have signed the Rio Declaration, led by Fiocruz, at #GPPS2024 🇧🇷 Greater collaboration is essential in order to ensure equitable access to diagnostics, vaccines, medicines, and other health tools. 🔸 Read the declaration in full: portal.fiocruz.br/sites/portal.f…

'Too little, too late' - a The Lancet editorial calls for more funding to support prevention, treatment, and surveillance of #dengue. We urgently need innovation - there is currently no specific treatment. 📖 thelancet.com/journals/lance…

I think Bluesky may now be a better platform for global health topics and sharing news about neglected tropical diseases. I am there at Charles Mowbray (@charlesmowbray.bsky.social) — Bluesky

Sharing some thoughts on opportunities for Host Directed Therapies for infectious diseases that affect neglected patients: bsky.app/profile/charle… linkedin.com/posts/charlesm…

Our Discovery Director Charles Mowbray spoke about the need for research and development on #NTDs and epidemic & pandemic diseases. Watch the recording 👉 bit.ly/4hNXCrn 📺 Thank you GHIT Fund (グローバルヘルス技術振興基金) for hosting this important forum!

An exciting and important opportunity:

The European Commission’s new Medical Countermeasures Strategy could be a critical tool to support end-to-end R&D specifically as it will support pandemic-prone diseases such as Ebola or dengue. [1/4] 👇

🎉 Our annual report is out! In 2024, we advanced work on 🔬 32 projects, including 16 clinical trials in 7 disease areas, conducted across 🌍 60 sites in 23 countries. Browse our report to learn how solidarity in science is benefiting the most neglected: bit.ly/40Q4yy8

Are you going to #ECTMIH2025 in Hamburg next week? Our team will be speaking about epidemic and pandemic-prone viruses, neglected tropical diseases (#NTDs) & female genital #schistosomiasis. 👉Find out more: dndi.org/events/2025/ec… #beatNTDs

JUST RELEASED: Open science in a closed world 🌍📘Our new policy report shows how open, collaborative science and pro-access IP approaches can accelerate medical innovation & equitable access to health tools for all. Read more ➡️ bit.ly/49oSWaz #MakeScienceOpen